Publication | Closed Access

Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)

UrologyPancreatic CancerS-1 CombinationGastrointestinal OncologyMedicinePhase Ii StudyCancer TreatmentOncologyRadiation OncologyCancer Research